NCT/Study#

NCT03424005 /

CO40115 - Morpheus TNBC

A PHASE Ib/II,OPEN-LABEL, MULTICENTER, RANDOMIZED UMBRELLA STUDY EVALUATING THE EFFICACY AND SAFETY OF MULTIPLE IMMUNOTHERAPY-BASED TREATMENT COMBINATIONS IN PATIENTS WITH METASTATIC TRIPLE-NEGATIVE BREAST CANCER (MORPHEUS-TNBC)

A PHASE Ib/II,OPEN-LABEL, MULTICENTER, RANDOMIZED UMBRELLA STUDY EVALUATING THE EFFICACY AND SAFETY OF MULTIPLE IMMUNOTHERAPY-BASED TREATMENT COMBINATIONS IN PATIENTS WITH METASTATIC TRIPLE-NEGATIVE BREAST CANCER (MORPHEUS-TNBC)

DISEASE GROUP:
Breast Cancer Clinical Trials
current phase:
Ib/II
STUDY STATUS:
Accepting Patients
Location:
Howell, NJ
For More information: